As of 2025-07-06, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (25.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -234.4%.
The range of the Relative Valuation is (21.60) - (29.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 24.0x | 18.3x |
| Forward P/E multiples | 14.7x - 19.7x | 16.4x |
| Fair Price | (21.60) - (29.00) | (25.53) |
| Upside | -213.7% - -252.6% | -234.4% |
| Date | P/E |